(Arg15, Arg21) VIP: Evaluation of Biological Activity and Localization to Breast Cancer Tumors

This publication has 17 references indexed in Scilit:

• One-step synthesis of 18F labeled [18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling
  Applied Radiation and Isotopes, 1994
• Multiple receptors for PACAP and VIP
  Trends in Pharmacological Sciences, 1994
• A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
  Proceedings of the National Academy of Sciences, 1993
• Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells
  Peptides, 1993
• Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
  Neuron, 1992
• A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes
  Brain Research, 1991
• Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels
  Peptides, 1990
• Vasoactive intestinal peptide and electrical activity influence neuronal survival.
  Proceedings of the National Academy of Sciences, 1986
• Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity
  Biochemical and Biophysical Research Communications, 1984
• Comparison of VIP-secretin receptors in rat and human lung
  Peptides, 1981